About Careers Internship MedBlog Contact us

Skin Cancer Risk Doubled for Teens Using Sunbeds

by Rathi Manohar on August 2, 2010 at 5:58 PM
Font : A-A+

 Skin Cancer Risk Doubled for Teens Using Sunbeds

Teenagers who use sun beds are at double the risk of getting the most dangerous form of skin cancer than those who have not been to a tanning salon, warn researchers at the University of Melbourne.

The earlier sunbed use begins, the greater the risk of developing a deadly melanoma before the age of 40, the research revealsed.


It showed that those who start before they turn 20 are 88 per cent more likely to be diagnosed with a deadly melanoma than people who have never used a sunbed.

The research is set to add further weight to the growing campaign for a total ban on sunbeds.

The study involved more than 600 people who had been diagnosed with skin cancer between the ages of 18 and 39.

They found that 23 per cent had used sunbeds at some point in their lives and on average they had started using them at the age of 22.

The risk of developing a melanoma was found to be 41 per cent greater among the sunbed users.

The risk increased the more frequently sun­beds had been used.

If the participants had used a sunbed before the age of 25, the risk of skin cancer compared with 'never users' was 64 per cent higher.

"The message here is compelling," the Daily Mail quoted skin cancer expert Dr Conal Perrett, from The Cadogan Clinic in London, as saying.

"The researchers showed that sunbed use is associated with an increased risk of early-onset melanoma, the most dangerous type of skin cancer.

"This risk increased with an earlier age at first use. Unfortunately, too many young people continue to use sunbeds without fully appreciating the risks," Perrett was quoted as saying.

Source: ANI


Recommended Readings

Latest Cancer News

Combination Therapy may Benefit Leukemia Patients
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
 Myelofibrosis: New Drugs to Revolutionize Treatment
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
 Blood Vessels Can Kill Cancer Cells and Stop Breast Cancer Spread
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
 Weed Killer Agent Orange May Increase the Risk of Blood Cancer Among Veterans
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Two Years: Optimal Duration of Immunotherapy in Advanced Lung Cancer
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Skin Cancer Risk Doubled for Teens Using Sunbeds Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests